throbber
cspaccnct w Bibliographic data
`
`Page 1 of 1
`
`PROCESS FOR PRODUCING SLOWLY DRUG-RELEASING MICELLE USING
`CONJUGATION OF BIODEGRADABLE POLYMER AND ANTICANCER
`AGENT
`
`Publication number: KR20020041712 (A)
`Publication date:
`2002-06-03
`Inventor(s):
`PARK TAE GWAN [KR]; YOO HYEOK SANG [KR] +
`Applicant(s):
`KOREA ADVANCED INST SCI 8: TECH [KR] +
`Classification:
`
`A61K9/127; A61 K9I127; (IPC1-7): A61K9/127
`
`— international:
`- European:
`ApplicatiON number: KR20000071400 20001128
`Priority number(s): KR20000071400 20001128
`
`Abstract of KR 20020041712 (A)
`PURPOSE: A process for producing a slowly drug-releasing micelle using a conjugation of a
`biodegradable polymer and an anticancer agent is provided, thereby the drug releasing rate can be
`controlled, so that the slowly drug-releasing micelle can be useful for treatment of cancer.
`CONSTITUTION: The process for producing a slowly drug-releasing micelle using a conjugation of a
`biodegradable polymer and an anticancer agent comprises the steps of: copolymerizing a
`biodegradable polyester polymer and polyethyleneglyco|(PEG) in the presence of stannous octoate
`under vacuum condition at 160 to 200 deg.C for 2 to 6 hours to prepare a block copolymer having both
`hydrophobic region and hydrophilic region, wherein the end of the hydrophobic region has hydroxy
`group; dissolving the block copolymer in an organic solvent, reacting the block copolymer with a linker
`compound in the presence of pyridine and nitrogen to combine the linker compound with the hydroxy
`group of the block copolymer; reacting the block copolymer with hydrazine and combining the block
`copolymer with a drug to prepare a micelle unit: and dispersing the micelle unit in an aqueous solution.
`
`
`Data supplied from the espacenet database —— Worldwide
`
`http://VS .espacenet.com/publicationDctails/biblio?DB=EPODOC&adj accnt=true&loca] e...
`
`05/27/2010
`
`

`

`(51) 0 Int. 01.7
`A61K 0/127
`
`(11)§71111.:|§ $2002- 0041712
`(43) £71010 2002fi06§03€é
`
`(21) 55131133
`
`(22) $110510
`
`10- 2000- 0071400
`
`2000kfl11§28§
`
`(fl)%%m
`
`fiaflfiflgfl
`%%%
`
`wa%g??®%3m-1
`
`(72) 151951111
`
`11115131
`EHE£11341111911311EEJ§°£A§10101§211— 1501
`
`11111151
`
`(74) E11318!
`
`011.1%
`
`(54) fi§fiH€1 31113- 71191 %%X1101 fiiiflé 01%?1 1115-1301/57110121 711135 1'31”;
`
`£1.91
`
`E §§~E~ 11115—311151 1%?— X1E~ E1E1X~11%0101““£31 151121111111 37? 1%0—11’510111-1 01045501511191: 1-1115: EI’EEINI
`
`9| I11231$1H £11 11171011 .4011 015101I11fii 21151125 D1QK11X11011 11121 71011.11. 1% 151195121 111112151 D1§I1II11°1K11£%1‘=‘1;;1°
`
`*OH—E-éfl’ej EBE1101J~E11fi71l fl~EX191 %E1011%%11§F1%(PEG)7=1I 1113-7113 £§fi1fl1~3119111 gag—511x115 51-331:
`€33;
`75.1.71 131E 3§§1£11§ $5171 §1§1mfi1 11.1%}4911‘1 $3 13%?01511101 "31011-231171011 E171 §1§1E§ Qfimlflto3‘—
`
`18; E3171 W1 £01 EEEI «317“;- WE‘EMEE ”@311 71151117111,"1%111 gag €5§§1fl171 74193151 %4EH9.1 0311|E1$~|7111§
`
`$Efi§ 131%; 311 752171-1-=15:1 1311*“1311fl1§¢§°11§01111 Eflklfi 111121.113.” £1111X11X11rm X11561: 95-12% £§1E1E1
`
`E ”21121011 218101 X11$§J 111311113 Ekyflxfifi @8101 9-1-2191 $10155“; éfllxié #— 53111, 01329.1 135% 1’1-
`
`~E~2E
`
`111—1:
`
`5319;15- 11112537111111.1155 DIQYHIWE- E121711E011 EEK-12$ 13%“ 4: $31" 7101121.
`
`121131.53.
`E. 1
`
`15119101
`d
`
`

`

`E 1% E “amci‘ofl 2|?! Mtg? Ui’gNiMiQ—E 31255535229 EMERE L¥E+1rli legion}.
`
`E 2:": 2£$HWOI £3.41?) H§§§ ng$iifi2| fiffifi'fi-E EQE‘EE HEPkfi HEOIEL
`
`E 3-S— fiolfiéflffig Gigi? E¢$Blfl0| gaa H'ggs‘ fil’éEW—Efilgi Xiififi‘flé EMEEE LéEiLafi ZLEéiOlCi'.
`
`E 4-‘5— M6041 £qu Ei$fild9~l £744 ggagg. LPEHAE ZlEHEOIEIn
`
`E. 5-:— gfi'ar’HiflJj-l’ E Q‘gP—l Eé-fiifliflol 724%?! Mrg‘ég Ul’g‘IHXiIQI @gfiP—Pg BEEP :LEHMEOIBR
`
`@E‘Xflfll Efiflg- 0%??? Mtggé U!§‘Nl£fi(micefte)9| Iiifi'éé‘fl'ofi E??? ZL‘OIE}. E- E-E
`% %%*Ki! %9—| 93%31} fifiklafl é, ¢%°—1”’301EM Dl’é‘ZHSg gé’SMfl'E HE;
`$1
`Elfimi KHZEE' WEE“; Bi’é'flflxfiofi E??? Z‘JOIEL
`
`gamma, ’efiflli—HE “Jig 751mm $153 figiflofl MgiiE 3.1%ka ’afiiflfigfi ENSEWLI‘ ’éfifl! E'H’EB‘QI ’ES'EOI
`
`EFFE'EL GEEK—“12%, OIEJ'EF 259.11% EF-fikia'ifi fl-EXPNEE §El0fl¢5fi2 QEEE 033—0473 NE”; éEIOHfiEfiE-fi
`
`7% $121391, OE-E Uififl§flfi§§fi§fi0M2l "55"?J% $0} 9.?5%Ef fifi’fiigg '&W 55-:— $§§ %§?M §2E 123*
`figlfiml HEEL?!” ‘EJCL 5.137% Magi" éEIOiIfiHIEQI Qfil’fifl WHEE, Eflififiéfmolyiactic acid, PLA), «EEEEI
`Eéflpotyglycoiic acid, PGA), %EE(D,L~ 3.5.1:)? co~ éElE‘MHpOEwa lactic- co— giycolic acid, 0173‘}
`'PLG
`A‘ E} Q), "gaK 9§£§§%), %EI(%3|§%¥'§), %El(%¥0|§ié}\§ ¥EIEHO§§) 9-3 %EI(3|'0IEE}\| ”ai'E‘IEHOI—E)
`'30'
`E’JCF. ’3??? xl‘éF-Zui %E|01i.”_~Efl§ fioflkii @1251, PLGAQ-l ’3‘?- an’E’bifi—f ”$31-$43" EFEOFflP—I 85%“; x’E‘fiHL—L 31%"
`
`X? i‘gEFE—g— E'jéofllfigfllfi, {I}??? Efl—“F-ES'E 3J5 fi—E—fifl’é“ "WE-KP“? 315%???EHE %%%§7§| Aka-Elli}.
`
`fiifi-Efifléj I’M-ENE ’ézt‘flH—HOHM @EM’JOI XILHE REVERE EEHEIZ’I [EH-EN! ‘iiflEOfl 75354 31% Ulfiixi EgEE? 0'4!
`
`E éCH, P’LGAEEr Q12? 7EKF~E @fiIi—HOHM E—fiflEICH gig—{‘32} EEIEfiEE “$339.10“! 9.373%”! Ngé‘i 5H7} 82C}. IE
`
`2%, gifi-ESHE' SEEK}; 01%‘5‘Ir04 gh‘Z'Eg EM“; Plfifli EE'EL“, 04E~Wxi 93:20“ CH’FSH Xléfi‘fl @éfiflé 711:3?
`
`65 QJEL $51, 213353? Mag Elijlg ~Er-QF3HOFE‘} %§§l §§%E% 9943??" £104 9:39} 337} LPEPLFE 9—?"2‘9 35'
`
`9r, 3%? 13-ng SEE-HE PJE QqFEEflEE" Eifliofl 3&0! @‘QEW‘H 510.3, SEE-HE} E‘fliQ—i Efi’fiml {HEP WEN 745%49.
`
`E $§E§EE 013,?“ Mg? mm 5%“? 9i§<>ii g—gaz $33K}. NEE-53 %*%7Ix—f% 34E Qflloflifl- 013.2?(micro
`sphere)2f HifiJ/‘THnanoparticleL fil‘éXmiceHe) %O| QXEHL Ul%?9-l 7539-5 21 217W} $39.3- 4*”41 UPOIEED!
`EVEEOIEH, LPiEXPE— 421% MbUWEEOIE, {WERE Z3313 QM LPiDIE'i LHQIOHZP. ENE-71E Iilfiilg' ‘33“:3? 9|
`
`3? gé‘gfigiflfi Mgflfli 33E Ef‘i’fiEOM WE} ‘3?”394 X14234?! gag—339%— ‘EEP‘! $13Hfi¥éa§3ll Hk‘émtm ~§§
`
`3&4? $fo% EEQE 3|": XfiIiEOIBi (33%.?! xii-35491 gig- $235 %J\E0fl 4"%x49! @MIE Xlfikg 3W M§EI~E 9?
`
`$7515; EflEGIEfi, 51% 0—134 %ME* {@EEH Mg‘fi 3%“ 3355?. LFh‘PAXHJ [Egg OI-gfioi @‘émlg $04€f9i
`
`{Pi—31011
`
`kl ¢~flLFh1EIIE+Ofl 033*:- ‘IQRQI fifll [EH-$043, EfigiLH idliEEiEOI hé'fl EHEEEEOH-E E‘JEifOI ”333%, {SCH
`39.2% .séEI-EHILH MIE‘BEOI 43%]? cé'flfifififloilfi ENE “3%? 3f— BEEEE *J‘éfxfiéll Higol’éié EEIEQE “31‘
`
`

`

`E93, ?I._0 E;E- MI%”II EMIIIOI—IIII’II I9! GILIE gIIIOII XIIEIEE III-I513 EJEEI’E- ’IIOICZI 3-? IEIIQI 9%
`751% ”III—II III—OH .7127 | (III—”£- EIIII511 EEOII 334: 9&0! III/$9.] II EHEIoII-Elm 357! III? IIISI IE EIIE, Al
`ELIOI KI'IMI II’IIIIOOII: IIOI‘I?! EEIIICIIE IIIE5% OIIIIIIIOTIIIAIII‘JEII EXIPI III’éIJSIJII EIEI. :I. QIOIIE
`
`VIII! LIIDII EIIIQI ”as If}AIHOI III III CI'II‘EI QII‘OI III- IIQEIII o—IEEE l'IIIIIOI XIIXIIII THIGH—I WI 5in
`EIIIDIMI0“" IIIOI I7E KH~E~0II IIIIIE XIII.III IIE-IIIlLHOII IXIIBI:“II-02| 23L;— ZEAIIIHEIEI, SOIL-WEE. oIIISlI
`(III)! III ZISII7I EIEII: ZdEE OIUI I’f-III'IEI I’IOIEI. EEIEIM. HAIIFIIIII EIE.’ (IIIEIOI III-2| III-III IIOIIII «CI—I
`IIIM kI—‘EIBIE SBIILI.
`
`EIEI, 3:. EIXIEEI III‘IOI £3377le I‘I'Is’:$H|§LIIdoxowbicinL OIEEIOIUIOIMadrEamycin) ALIS—fir BIEWISpIatin)
`EIII-(’(IIXOI), 5~ $$EE$EIM(5— fluorouracii)%2°I§% AIg—EI EI‘II filfiOH‘IOI m'IH‘I‘IIIHI AIg-EJEOLEI
`ZIE—ILI 9517! EICISIXIIIT l'IEflI $33-3fi OJSIOI 13%” 504?; 3? 029W X|§7IWEI QEQI ”Ii" EOIBIIEE EIXIOII
`
`7I| QEI 31%; 7IX=ICI~I~1 Silt: QEOIEI. GIEIEI ¥5Igol LIEILIIE ERIE ‘SOJXIIBI HIMEH’S EEIIE <Bill-ll. 33%?wa
`EMIEOIEEE’ ngIKI SIZE ‘IIIIEWIEOIIEE Egfl’giw QMIEEI% IIEAIE’IIIEA0SIR, @Jgflfl HIE—QI ’E‘ZEI'E 94H,
`EIAIAWUI CEIIE-OII ERIE fi‘é’f J; I _77I7'II HIE ”OIEI.
`
`{EIEIA‘I ”WEE? "IIJEIII’S—IQE AIU‘WQ 4“ O'EIE‘I ECI EIE opp—i SIOIIXIIIE $04? -’II 33234 [[HEIOII gEIXIfiI iIEITfII'E
`IIIIII. IIOII I— III III OIE’IEISE IIIzI. oII IIIIOI IIIIIII IIIIIIIIIIII III III IIIgI III
`
`IOIIII III I trKIIEI-IIIIIIoI cIIII IIIII IIOII IIIIIoI IIIIIII IIIIIOIII IIIIIII III..- IIIOI II OI
`
`giljl QJEH’EI’EE: T. Minko, et al., J. Control. REL, 54:223— 233, 1998; A. (John de Verdiere, et aI., Canoe
`
`r Chemother. Pharmacol., 33:504» 508, 1994).
`
`0
`:IE—ILI OIaI:I IIIIIII IIIIII IoIIIIII III OIIIIIII IIIILIII III IIIIII III9.; III LIIIELII—t—
`
`IIII IIIIIoI III II OIIII IIIIIII III LIOIIII IIIII III EIOI III-IIII IIII IOIOIII III.
`III LIEIIIIIIIII IIIEIH, OIaI: IIIII III“II7I—‘IliIkuI-IOI 7=||IIEIJI .IIII IIIIIISHIE IIII IIIIIIIII
`oII CHILI IIIII 7III I oIIIIIII LIEILIII Its: III IIIOIEI.
`
`IIIIQI oII-«III III LII-"III IIIII
`
`OIOIII III—II IIIII IIIIIII IIIIIII. aI—Io II—IQI III III III—I IOIIII III-9.2 III—III IIIOI III
`
`II III III—III IIIIIII IIIIII III OIIII OII buaIEI III IIIIIII II III III IIIII III III I III III
`
`«III IIIIII III—III III/III IIIIIIIII III IIIII III IIIIII III! III UIIIIIIIIIIIIII I
`7
`fil-
`H
`55% QIEOEJr%%0I mOIKIEII II? Ell
`'IIE 25% 257%??? 5? ‘BI'E’I-EI «ICEIIIIE, % £233“ %%I’I'6I?II EI‘BECI
`
`g $3393 MI0%,; DIII‘XIIIIIOI XIII: ‘EI‘IEIE IMEIII’S EEIOIIAEIIEFII EEXIBI %EI0II%%%EIEIPEG) 7=EI Sal-EXIE “IE
`éI—IIEIIIIsIannous octoaie) 9| 5—»? IIIOIIIIIEHOIIA-I 160 LIIII 200°C2I 35.0% 2 LHXI BAIZI %EI IEIIIEII
`
`

`

`Maw, EFEOiE-E was $5: mm, mus»: Mo“:— {aim/rag $E§ 27mm. 42% $2.21 @3041 fifOXE-EAWIE
`
`7%:— §% ggnmg 4:51-ng 432%; am ~32 gag: 41% %7I%BH01I 13mm, gamma mm @429. 54H
`
`«am am a gram 39%Ai7fl-L a»; gagging: E‘POIEEAED’IOH gm afig Emma 55%; L374 ikfiffiw 2.3:;
`
`El «g2 flaw-:- s—tgarm “fifiklamw 52-3- {Pgwkii’EXl 9.5—3 *2 9323+ g—qgrgwlaw. argm as géfiffil
`
`7; 746% $391 mgggmla- #E—‘éPE $754. 34. am $23? avatar-91w;— #go-fi’gow JEAMW Haggai mew:
`
`wig Xflzfifirt— ads»; mammals: 5 1)
`
`’g—ELEHQ galouaazgfin fl-«EMQf %Ei01laalfl%EI%—(PEG) 741 fl—E—Kré %§&¥¢.’ifl°§(stannous octoate)9.l @363}
`Oil EE-‘gEHOiIH 160 LHX1200°C2| @501W 2 LHX! 6M2) £53 €§§EP%AI%IM,
`EFEOE-‘a— infrig $E¢§r 7MB;
`
`12% EFENIE E¢é~§ ~%‘~%r:‘-% 7+XID=L 5.239193 $§2I $9011 EPOIEEADlfi 7+x‘lfi 5% $~§§ifi§ #EEM: OIIIH,
`galmmafléfii 1%75}E éalwéwpm). gaiQEIEMPGA), %EI(D,L~ ”figgh co» Jabs/ck, PLGA). éak
`flail—“1%), g3“ galaaraé), gens-WHEN l-?-‘~Eif~1!|0i.é=r.) SEE“ gaKfifOIEEAI gamma); Mg? 4> EJQLL
`PLGAg Mgfim NEE—16m, galgflm Etéfig 50:50(%HI)2§ Hfigxlfi H.753? PLGAE APgErOI 7%! 3%
`546%}. éEIOflan-élaiéfi! EEK}? Mlfiklfialmégc‘afigaamethoxypoiyethy:enegiycoi, mPEG)~§~ Mgflm H?
`
`x41 2%: %% gfii 1:94 7I%719.I%Q§}0419|E+ @342: m:
`
`g; g§§ifl§ %71—g~a§ofl gig-Mam, QEOHM EIEIEJP—P £15221 §XH3§~041 @fl ékfliflk Egg/WW. 5% "a?“
`O
`
`IEEJWEOH 55.14%! flag—g? Eflkli’ém: ohm, %7E%DHE 2%?! KiiEFEli‘: 72% OH—ELi, mtgwaamol
`
`01»ME .ZL; L9 .2:
`2 2 [BE :11[EU11 HI g .9. 1m C30)9 H:
`2; 0%) W 4)- :2 f0 1“,: 1? 1“. 1mH“ E 5115. mm BU H11kl DIIiI r: 11?. Rik) : 030 £19: 2 E 13'! .1?!
`6M, EhE—AE a2 €§§WL ao'awi firfli ,-.' EIEIEJQ EEHI-‘é—E 1:2:2 Lax! 1:2:6(%Hi) om, argxmg 2 LHI! 6
`
`Ir
`
`is
`
`.9. min Lg 1::”MI 5?; «H
`
`Eels-=74 ifEEOI aw ~32 «g—éwfl warm nglaw—M 55:- ar—g-Mm: reg—s i, akin} «Emma-w, 9:
`
`gm ~32 g—gmm 734%: §EH9| WWW; $~E~§Ffik om, 6:35am 6% Izl a 123% gw '11-‘55 733%
`
`agar-um as? @201 9%94 augmr wam magg—ela-cu—g- fisgam, filaarflm argxlalxt 9.5% 22171 1%
`
`ga—wa a»: ggwal @474 $on 9:59.! cream gram E1!§‘E~?~l7‘cfi% figgéécg. 5.3 9$§~E saga mt
`
`W m 9;th %£¢$Hiéj, orgalomrom Aiég—Ef'fii,
`
`lad-g, 5~ gfirgagag $59.1 mung maggot mgr—248+
`
`1:}.
`
`xfl 423-78: Hfifié Di’gfimlfli x413:
`
`E?! #573} Df’éEf—?-I'§% $%°—.”§04W EflMfi, HE??? BI’QNWE 393353311“: 5 Wfifd 3&0! 934‘s? 36$ OISE!
`0
`0&9“?ng 5F§°~1Hé§0f|k1 EQMWEHI Effld, $211284 %‘%"301§ 93‘5“}04 MEX—152$ [31% :PZE-E- figs-p.” Em. 0W
`i
`|
`0
`Id
`as gag/3% MW; Sigma éflifl 23mm 7+~¢ESH 3. .1522; wag: mm 2%» 0% 3;— Néem. 3-351 9%
`gg 3%; g—fig'flsz 752mm ega— 9:%m %%;?3 53+;- mm; Eta.
`
`

`

`75:17I $0300 2%?021 IEE E guégl Hg??? fligximlt— mag-2|- Q—E— 5—18
`
`giffifiofl swam imam; Qfl‘figfiw $3519.; 9&0! ALEIM g
`
`§~OI QWEAQ; £79m, 90%| mg aéQOI 7%? sawmill figfigim #EQWMEM K '34
`
`0| EJEH éi'IxH, 000w 3105MB! E‘é‘Héfi‘EOfl Elléfifi 91%0I W46: ‘24-?
`
`t—
`
`7
`
`1115‘,0:1ESE:
`
`E, 5 $453,404} QIE'HH 31.75%} Hfi? Bigxfixfifl ’éfiflii—H ‘1.*%3—f(pharmacokinetics)% EVE-Tl} EFT-l": GHQ $15.13 6.!
`HH§(renal exciusion)% EETLI'FS'WI 3E? 5E9 OH-EER ¢%~%*fl(passive diffusion) Oil 9&3?04 £H¥$l§ gig—9! 5;
`$Ef®(vascular permeabiliiy) 5% *fiolf’fi 5J1. (”£34, MIELHOiflendocytmeQ—l E7? E1: cl.*3CiII:-W!LH’.5’(muiti
`- drug resistance, MDR) EEEE 735:0” 9|fif0=l ’gfifLHOHM Ul’éfila‘ig QFESI 42$”? gnaw fill SEEP, (JEN!
`EEFE‘ F’LGA @7310! $343122 E—fiHEEEi‘A'i $‘géfi 94‘5- PLGA @ELEEH Eil’éfofikf “3&0! HHfi'i E'JfiEW “EH”,
`
`E gag—91 A‘l‘ififi DIQXfiHiP-E xififiweé @‘PJXfiE “£393 @fi‘mwa-Hlfii-g— Efii'fif-‘E flagged BE’é‘flWlE‘ NBEE‘PI, CHEW
`
`%EH9—i Gigi} Hlflfirfig— 7§$, EF—E
`
`EX} } @“fliwg %El’5—12§ 3‘36"}04 NEE" fll’afiOfl HWW flfigl @‘gfil
`
`0'
`
`E
`
`'
`
`0?%E~L é? 3%94 Hfi‘é‘ UIQXMM EEHE-l @‘éi'xflofl HI
`%
`
`Olé'h Qkiofiig %6%~04 % gag—g. EC} ”gldlfsl QE‘D‘EPEX? EHLL 01% @MGrlE-L’: SEEM Ei fi§§ EC? :T‘lfil’sigi ”£534
`
`‘S'UI 943* 729%, % EQ'E‘JSZI RIM [HEP % EDS'QJ E1947} 01% §A|04301| SIB‘H NIEFEIII E’sFEEFt- 3:98.- %fi’_—'17%|0fiki %
`{99! mag" 7m IHHIHI 9A01M 1&3? 710M.
`
`@1403 1: mPEG7f wax-'5: %E!01ii:Efl§.7=H JI—E—M mPEG» PLGAQI #%
`
`§EI(D,L~ Egan co» éaléMMPLGA) 269% E—Xlfi 7009 U+i§A|%EIO{|§%§%al%(mPEG) 2g, $003 335091
`mPEG 89 9-; vhf—NEG?“ 800091 mPEG 1693* 2m garaaoflfi 10mm, Qfi 7E7?“ any-stow 140mg 7kg~a~+o4 gr
`75351 fififlkéi’ifik OM, {HE-EWW 75.47141 §%£I 0.05%04} EH'E'ETPE gifififi'ff‘fls’tannous ontsate)% 7E7??? 3,
`180°C€>€EM 3H?) %?J w-S—Ali‘ith 010+, {jig—2% UiléQQéEWIQmethytenecmoride)2} Eggs}; KHMI Law
`%_| CIOHEE'GiIEfiE(diethylether) 01! ”5175004 *m‘fiézktfl Egg Hggmfi ems-+31, mafia-WW “525.1494 mPEG-
`PLGAg -”F%~‘8“f‘21'EL 1% [1%, QEEEP aimglawkgel permeation chromatography, GPO) El; Xf7l-3-%§'~E~éi7i
`E“ Mgfifoi EffiEl mPEG— PLGAQI 1%Kfaohél $Qflfl, Alil' 54% C’éfifllwifferential scanning caiorimetry, 08
`C)% M%‘c’5}04 {DI-5'53 Q’SQE} &E~ é’ééfii’fEH'étZi: E 1).
`
`’
`
`-xmgnggfwmmrgn (Mn)
`PLGA- PEG750
`: 300
`
`(59001! QIEP—EmaMn)
`.
`
`PCO€§QI§EKF§WM
`
`I 000
`
`DSC(°C)
`21.
`
`’
`
`PLGA- PEGBSSO
`PLGA— PEGBOOO
`
`; 600
`
`3
`
`@1401? 2: mPEG— PLGAE? %£:-?—H§&OI EEEI MEWS? Dl’flxfixfifif MESS
`
`2147i #Eéd mPEG PLGA 391m 53574 0022! p» LIE§013Lé§§E£§0P§ 80mg" 3001294 NIEa‘EfléiErOIEOfi %
`SHAWL 03mg: mampyridmewg jam-aw §£7li11fl0flsfiii§§€+ Efikli‘m. 0M 50%;; 0700 EIO'HEE'
`
`

`

`O’EIEfiE‘Oii aflfifoi E’Eiflifi’b‘l, ”SEEE' 7+§§0|0fi Oiflfilafl $31, EEZEZ‘WIM ZjZEMfiE}. {135%.} Fig—E 025g§
`El[HlEE'E%OWFOIE(dimethyiformamide) 7.5M301I %3HM7|31, 10m99| gfigffll’MMOXUrubicin— HCI, Sigma Che
`m. (30., U.S.A)
`‘34 6.7551192? §E|N1E0}9J(triethyfamine)"3'" $37}? $1, QE‘HIM §$7Ii§|%}01124M§%8F Wig—kl
`flkl, gdtg-BH‘JOI QEFE’ DI’QEEQWE 4‘~%%P?§Ef(’3§: E 2). 7537? UEQEF-‘fllifig 37¢} é-rEr—‘F- 800M301! EMSAW
`"fiififlfi‘lol Q‘afl Hhéwé’ Ul’é‘filxflé fi’és'b‘fl, ”éEFP—E 3%? éwmrgf- 36 S“ Mgfifoi 55W! 3:314 éflxE‘BEW, 513%
`E-(élflifl QEEIII 973% Efififilfl-é- Xfififi‘ififl. 010‘}, 593% 541315903; @é-é-HIEOE @3313! kl??? Ul’é‘flixflg 2-“
`
`131 "él’EjMi‘ 3%,
`
`’8%°—‘1% NINE—+511 %§Z:|E’E}~E94M, gfirfiififfiol @E-‘E—E Ul§9$lifi9~i @EHE Efifli’fifik
`
`25m wag-ow, mPEG— PLGAOH CHEF éfi—HIMQI air 52% 6.313%! azgagling- omsoon gaHMzJ 4?, 5—42;
`
`74:; Eiwa—Hlélfii an; @3904, itiOfi an? gay?-
`
`12s.: mm! Hlfié gig-swcuga; a; 2)“
`
`I
`
`fl 2 mem WLGAM? EH??? aimfie’wmfli iii?“ g???
`3
`
`5
`
`1|
`
`DOX~ F’LGA» mPEGBDUO
`
`—3
`
`{371352 20M 51%ol, mPEG— PLGAOH cm E¢$H1M9| Efifififi 34 LHX! 38%(w/w) elm, UI’éE—‘E’WOM %
`fiéHi/flfi— 2.2%(wlw)% fixlfi‘mfi" °a* 3% ‘EA‘EJQ.
`
`”$404: 3; agar-é 535%? éfiPE mPEG— PLGAQ-I 59%
`
`mPEG— PLGA 3931+ “2157+ EPEFQEJ p- Llififll‘ééflfiigfl‘a 80mg 30M£2| Mligfiééakoigofi gmxaam, m
`EIEI 63mg% 7:247}? fez, *JEOM gamma: BMZJ%PJ HgAIiI 13%, ’éflEl £I04E5a01sfi+laml
`€47é~8+0=1
`fifikl‘z‘fi
`12?. GIN, Efifié 04m 53-; {iii/K512, CW UHEEfiEEEWIEOH géflklfl é, Ewfiml E'WIEEPEJWydrazine, NH
`2— M412) 2mg0| gfiafid Mflfiéifiwfi %%% EF‘éIE‘iE 5515513: aflfim, 743% anaiew 3A1:+%$3£ Maw
`
`Eié-gixii'm. 3%: rig, wig—2% gala EIOfiEEIUiEEiIEOJI imam ”SHE? é, Egg—g- owfim EZEAWM Tamar
`
`{5. WM Q‘flél mPEG— PLGAE 3%
`
`fififiifififi: E 3).
`
`QUIET-114: 5158??? @1947} QEE‘EI mPEG- PLGAEP @ifiiflifloi QQE Mtgfics‘ Ul’é'X‘JWl-Ql Xflé
`
`gklofil 304W é-F-q-E? ‘a‘lEEhfi WM 7:353 mF’EG PLGA 0.25gm 10mg£2| £¢$at¢d§ 7.5mm Elwit‘gfifiomrol
`E0“ gauze-4:11, £30m §i7li+123+on2mlar%a& Big-Mfi/H Edfi—HmOI 2'31”?! DIQEQLIV‘HIE #E—EP mg, 751
`
`7| DIQEPSRWIE— 1m éTarafi 300M20¥I flux—2'4 Ei—arHWOE EEé‘S—J Mm; BIQNJIRIE Ewan, HQEQI 37:} éTEr-Js
`
`39 E Mgfim, 5‘104I éii $44EFQEW, DIQEQWRP éifim em Ei—Eridlél—E HEWIEWiEP. 010+, Eli-EM Ea!
`6&04 E¢$HWOI éfiii Mg??? Dl’gxilxéié 73w EEMZ! 3%, §%9fl~§~ Xilflfim gzgamw, gé—é—BEHGI é:
`fiEI U1§E+$Ifdiszi 3334?. Eték‘iffim £13.: 5 3).
`
`§*|0412011A€9f%0a'§"
`
`téé'i'ziei, @flz—E‘FHWBE £33? 3%";- é’gfif‘flflflfliz E 3)
`
`

`

`
`
`{fl 3]
`@Efl€§§w%%§
`Dex~ we» rupee-mo
`
`
`‘§%§a%w%mn
`o
`
`28.32%
`
`
`nox- PLGA- maessso
`27.11%
`DOX- PLGA- mPEGBOOO
`
`
`
`’3713: SON/d E’E‘Ol, mPEG— PLGAO‘H CHEF gigflififl Eiifig 26 LHXI 29%(w/W) Olfli g£$3|fij illl’éll‘é';f
`$Ifll04l/H 5¢$Hlflg 1.7%(wlw)% iglér-‘é 811' 4‘“ $253111}.
`
`glklofi 5: Mgés' DIQEERIQJ x113:
`
`7SUI $10412 9-; 40M EEEI 2¢2¢2 gig—HMO! 22%? UIQEQ—Iifi 100mg§ 10mm OWEN! %6HAE?IE, 01%—
`100M253 35:} éEriF EWWEM 6M?J%°.J Ewfim OWE-g éflgkiiflki gm—“Tn—BWOI Qfisfl WW3 Ul’é’fiifilg HI
`as-arszéth 2% Di’g'BézlfllMl £331? mPEGQi @Kfimfl mar, £47| HIEEI %»¢$HIHOI QEEI Mg“?! mi’gXflXflQl a?!
`
`% DLS{dynamEc light scattering) fi'figi égfikg’zmyzs: E. 4).
`
`[5133 amnesia: ~E7i§§§f0fi HEEL gafiwwor Zééiéi mmmgé a7!
`
`Mfiéé DIJQEWI
`;
`,
`
`Dox- new mPEevso
`:—
`
`DOX- PLGA— mPEG3350
`61.48
`
`
`
`DOX- PLGA- mPEG8000
`
`; 66.21
`
`E 404W 5%“, fiag—BWOI @‘EJE‘ MEWS Ul’gx‘IiIXiIP-l a7l-EE mF’EGEZi «EI%%*‘EFE @flfi‘éltg- %? 4: 93921:}.
`
`“I“
`gmwaafifimamgaflmwfimgwmwmaéfimwM%§%ég
`
`gum; 50M Nasal ai—Eramm {3% gimme DOX- PLGA- mPEGBOOQg‘ 1mg/mE9J 135% Egfifi 9.1%.!
`$3??ng pH 6.5) 20ml§ $M%(diatysis bag, @Kr%fxflih @0300) 0+: E’zE‘Qfim, 0% %%J'é;+ §&%§@% 60m:
`0+! 2.22:1 Ewéfloi 37°CO+§M 16ng ”ail-afiw, géémg- area all? Enggflsafi 1321504, Eli?- EF%%°#011 EH?
`% afii-ar-Hlfijfll 93% @EMK—E— Olgfirwl 480nmow akg-armwa E 4). E 4% Alma! [fl—fi- %z:—E~F-Hifl9. $75-51
`$§§F§ HEM JEHEOIQ. E 4011M Eli-30L %A$B£MOI QEE! Mtgfié DIQNWIE ’eéi—E—SH’é slam}: alefiiOé
`$3104, XM'SEMH Wm}?! E~fiailag MM}?! @"3351-3 @ééalfilo: 22%| maxing-baa %d:-?~Hl{~_|0| “$713M!
`@504 MM?! %*%%% ‘24 ¢ 5329235}.
`
`@MM! 7: §fi|£fif EH53 Eiglfilflol 7Q§%J Jx—l'é*§§ UIQFWBI 73%
`
`%:’>_$—HE’§JOI QEE’ Hi??? UI’QHWW EiifilflP—i Hlflfioé fifl’h‘gfi ‘Eflflfizofl §$EJEXE %‘0fE7l glgfoi
`*m'AIOfi 201W WEE %¢$Hiéj0| Qfifi Ha}?! Evaxfixfifi‘ {Pg/filmaepsz celE line, KCLB<EPEMIE$E§))9+
`EWI HH‘éfMi' 3%, §§fi€l£§§§7lmow cytometryfl} TBBUVSVE Mg???“ ENE %%‘-§% EM‘5+9§EH§£: E 5). E
`SE $¢$HWH 1% £6,519] 5%5:$~|2H{150l git?) Mtg“? algmmml afarimg- BEA—11%|“ HEHEOIE}. E SON-i 3%0i,
`%§_—Er-HE{EJOI Z—éfiféi H‘i‘sméé DVQNWIE gi$fiifi§0fl HE'SH ékéifi “‘g‘gEP—PE Kiting? 39.1%? ¢ SJQZ‘QEH, Ola-IE" E
`flF-t- Eiifii’dm 793%? Mg? mgxwm MIELHO!?=E(endocytosis)-% §€7§04 $25le HEELHWE” 7{5_~i$(tragnsmr
`0.5304 Eigr-HWECP fliIELfifi 23.34% ‘EfOf 5;?! Eli-'E-EJ 712% 0474§JEL
`
`£333! £34»
`
`

`

`Ol’az-IOIIM ”EIMI‘SI "amé‘IBIl‘l
`
`KIM—113.13%— III/aw: AI;@DIQIIIIXIIBI mm;249—; 73:4 XIIE$IHQOII QI-anI HIE—E WW; nIMIxIIxII: xII-s—fiuI
`
`é‘i’fiIHE‘OI,I. gugg ACH-E—‘BH’S STE-XI; EIEIXII 5.01% EEI ZS‘EIMiI $ ¢§~°H€I0IIM
`
`E racism mafia aIM'xIIxIIoIxIEEESHQE AOHE aw % IOIIAEIIavII 315-» XIRI %EI0IIE=.'EJ%E (PEG) vII 2—5- XI% 395%
`7
`EIIIIg—WIAI, a»; sawIE —I~—=s 5 43—72;; {I
`I 2% géflfig 3334 fiIoIafiI EI°AI?=IAI ~%% g-fingIIQI 6I
`
`OIE§AI7I0II w IIaIfi QE‘AWIE gag; aaaI awe I74°IEI 5% 2%3IxII—ge mam flawfi'I/d argm %%
`.L
`oé‘flfilfl 33—33%: “542,4ng BIé—ilEWIflIE ¢¥I6 E 3’2: III, m *%::I DIJ‘EIEI"IxII-fi ¢%%6I05I1I% IIIIer, III-III:
`nI-IIIXIIIIIIE ms "GI: ain: EEIEIEI E‘— gIIIIOII szIaIOIxIEEI IIIaIeI DIQKIIXIIE §~=~IoI 94%;; —'-T‘:—OII%I‘% MAI:
`
`I
`4‘- ?Jll, QI‘EOI '3’? $55 33%;? 4: 53/3931: HI. ’Ei7 MEI-13% DI’éXIIXII‘gE EI‘c’IiIEOII EfiI’SLIEE figgg 4: (22% 33
`OIEII
`
`{537“} Efraisz ’gfiI
`
`gEIOIIAE‘IIEHI chKIQI @EIOIIEE‘IJQEIEPEGWII .mE—XI-E- 351‘.x"WI“?!IKstamnous octoate) °I
`I
`AI"0
`EIIOIIM 160 LII:I 200°C°I§E0II1¢I2 LFIII GAIZJ %?..I_'23-53;?" 8AI9=MI EIEOII: i452? $E§ 7?
`‘0OII‘f: 73.]WWW
`7I,X|D:I £4=é§ $594 ”EIEIOII E‘IOIEEAM73% 7IXIE "E“; E-éfliflé ¢&‘5IE
`
`EDI $31 €§§M§ %7I%D|I0II %‘5IIRI9I_I_ {SIEOIIA-I JLIEIEIF-‘Iax34.“.9—I @KIIEIOII %7I fiI’iI” III WgAIWH
`
`OEI E;.-»’\I?‘IOII aaaI EIEI‘ % EIEI’AIE’I: E‘sg;
`
`“EIEEIEJEI E‘IgAIflHI—I EBB” ELI—gMyIXI ”7?: $4, gffil'I -*~%%§:MI?=I
`(iii) E094} E‘IEIQOI EEK? fig €§§7€II§
`”
`._I
`' I
`M, ($531 $3 ~3§EHI7I @353 “EIIO algEI-IIxIIgé— gé‘ E 33E.
`‘4‘,
`
`(iv) WI 4%? Bk’é'EHH'II-E #wulgmw E—tIMal—E 4324—; EEI'ESI-E A”53% nngIIxIIQI was 23%
`
`E¥§2
`
`XII 1§0Il EJOIA‘I,
`
`(i )3 £421 galoIiAEIIEfiI m-E—XI-E EEIEIEJfimLA),
`
`%EI%EI%tI(PGA), %EI(D,L~ Ema/LEI— co- gaIg—wIPLGA), galIaIg
`
`3%), %EI( “EIEIIEEIIa, %El(€IOIE%AI
`
`ii‘iEIEIIOIii) 34 %EI(8I
`
`OIEEAI BEIEIEIIOIE)§ $é§§| :I—Euefi IIIEI IjE—‘IEJEI 1?;8! 33%
`
`5—212; fiI-L":
`
`AI 59% DIQKIIIIISZI XII£%I$I.
`
`0% $33 3.
`
`XII 1§I0II EJOI/d,
`
`(i r3894 éEIOIII-EEIEEIEHI Fri-XI?
`
`

`

`HgflfiflwEfigflgflmmmwmwmmmmmwmrflE®ol7*%
`
`go'QE 0+5"
`
`ME???» ENHHSXHE’J X1535 ‘35" “4.
`
`M 'gl‘ég Di’gfilxflal I1!2E%"'§;‘.
`
`H1§WONM
`
`(:1 )g—QBI gm 23+an p» HEEEILé-ELEEEfifi‘fi, arawagcl
`
`mmmgwmywwumaflmmgmaawmgma»an%a
`
`| 1%
`
`Era-<23 2-3::— éygg 6H:-
`
`Mg25.4 Emma mam.
`
`@¥§a
`
`7G5! 1%04I SEANM.
`
`112:2 LHII 1:2:8(%H1)?J 2.3% 275722; “EH":
`
`Aim%m$MMHi£%fl.
`
`g???
`
`HI 1%”)?! “2104M,
`
`m1%m%mwmo”+mw§%mg%3@mm
`
`

`

`§?§9
`
`) éaxop rag/g- co- aalgélMPm/xm NIEM%ElOfiE—fl§a§(mpm)% @374! git—8+3: @fswfl E, %
`(i
`Efi—fit—éitwéei 1:486ref! E—Efiml 180°CO1M'L2ME LHI] 62km %9.+ E+%Ai?=w mPEG— PLGA‘E 431E135 gag;
`
`) mF’EG» PLGAE MIEE‘EEEI-OENI EEHMWE JEOHH J'IIEIEEEF @359! EXHBWI p— L—IEEEIQQEEEE
`(ii
`13%?31} E'lEMfiH, mF’EG PLGA 0! ’POIEEMl’IOfi p~ LIEEIHI EEEEEE’HQE EEMB’IEo3’3';
`
`(m) p- LlfiéflilégifiE-fi- H930! 533%.! mPEG— PLGAE EfizfiéalI, omalomrow Ming era, EEK—$— l“-E 5
`~ ——~2i°EH—=J°i immilfik 3%7é‘fi**15’4 fll**'EF-‘%tx%l% #éfi—E “575$; 34,
`
`(m 7.1471 $5773? mag-a2; 15% ¢gewo+w «Efikifi‘i-‘E gag-g— EEWE E*%X41?P“‘§$E M+33 wax-mtg! £1521;
`
`’"éé-T‘%* 10.
`
`HI 9%91 fi'fiflofl BISM Iii—75%|, Eqfig—Hlt‘ol Zui'sJEF M‘géfi UIQKHHL
`
`Xil 93H?! 'éf‘fiofi 943M HERE E1, OFEE§0W§OWO¥ Q‘E’E' HERE? Ulgxflifl.
`
`

`

`EEK?
`
`flgfigmg
`L Egg
`
`'1
`
`,4E
`
`m:
`
`6T\\Mo
`
`0L"«1
`
`3
`
`5:33:12
`
`PLM:WREQ 7
`gag!
`
`31Hm»
`
`
`
`

`

`.
`HIV
`
`55:} 4&3
`3:: 10'
`
`

`

`£§3f1 4
`
`
`
`
`A]
`
`a} (9:12:
`
`Iam
`”3355
`
`
`
`
`
`
`
`
`21's
`
`
`
`1t:
`
`‘98.
`
`"‘é’fii’éfl
`
`éflBfiQ
`
`am mwmm)
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket